ClinicalTrials.Veeva

Menu

Transcutaneous Auricular Vagus Nerve Stimulation for Treating Post-stroke Dysphagia (LOGIC)

C

Campus Bio-Medico University of Rome

Status

Enrolling

Conditions

Dysphagia Following Cerebrovascular Accident

Treatments

Device: Non Invasive vagus nerve stimulation

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of the present project is to use transcutaneous auricular vagus nerve stimulation (t-VNS) for the treatment of dysphagia in acute stroke patients to improve swallowing function and reduce mortality and disability related to this condition.

30 patients will be randomized into one of the two arms of the study:

  • REAL: real t-VNS + speech therapy
  • SHAM: t-VNS placebo + speech therapy. The experimental treatment consists in the association between t-VNS (real or placebo) and speech therapy exercises to improve swallowing functionality. Each patient will undergo a speech therapy rehabilitation session lasting approximately 40 minutes a day for 3 consecutive days, simultaneously with t-VNS on left ear.

Swallowing function and clinical conditions will be evaluated before the intervention (baseline, T0), immediately after the intervention (T1) and 3 months after the intervention (T2).

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Acute ischemic or hemorrhagic stroke (within 7 days of onset)
  • Dysphagia diagnosed by FEES with a Fiberoptic Endoscopic Dysphagia Severity Scale (FEDSS) score between 3 and 5

Exclusion criteria

  • Pre-existing stroke dysphagia
  • Dementia or other medical conditions that may interfere with the study

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

30 participants in 2 patient groups

Real t-VNS
Experimental group
Description:
real t-VNS on left ear for 40 minutes, daily for 3 consecutive days, simultaneously with speech therapy.
Treatment:
Device: Non Invasive vagus nerve stimulation
Sham t-VNS
Active Comparator group
Description:
sham t-VNS on left ear for 40 minutes, daily for 3 consecutive days, simultaneously with speech therapy.
Treatment:
Device: Non Invasive vagus nerve stimulation

Trial contacts and locations

1

Loading...

Central trial contact

Fabio Pilato, MD; Fioravante Capone, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems